1 / 43

HYPERTENSIVE DISEASE OF PREGNANCY

HYPERTENSIVE DISEASE OF PREGNANCY. Prof. Mehdi Hasan Mumtaz. MATERNAL PHYSIOLOGY. Anaemia. Hyperventilation. Hypovolaemia. Hyper-coagubility. HYPERTENSIVE DISEASE OF PREGNANCY. Pre-eclampsia. Eclampsia. HELLP syndrome. PRE-ECLAMPTIC TOXEMIA (PET). TRIAD Hypertension. Proteinurea.

maille
Download Presentation

HYPERTENSIVE DISEASE OF PREGNANCY

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HYPERTENSIVE DISEASE OF PREGNANCY Prof. Mehdi Hasan Mumtaz

  2. MATERNAL PHYSIOLOGY • Anaemia. • Hyperventilation. • Hypovolaemia. • Hyper-coagubility.

  3. HYPERTENSIVE DISEASE OF PREGNANCY • Pre-eclampsia. • Eclampsia. • HELLP syndrome.

  4. PRE-ECLAMPTIC TOXEMIA(PET) TRIAD • Hypertension. • Proteinurea. • Oedema.

  5. SEVERE-PRE-ECLAMPSIADefinitions • BP> 140/90. • Proteinurea >0.5 G/24h or >2+ urine analysis + Epigastric pain. Haedache. Visual disturbances. Clonus> 3beats. Platelet count <100x109. ALT>50IU/L. OR SPB = > 170 DBP = > 110 PROTEINUREA >0.5 G/24h OR > 2+ URINE ANALYSIS.

  6. HAEMODYNAMIC FINDINGSSevere Pre-eclampsia • Low plasma volume. • Low /Normal CO. • Low/ Normal CVP/PCWP. • myocardial contractility. • Low COP.

  7. ECLAMPSIA • Hypertension. • Protein urea. • Oedema. • Convulsion.

  8. HELLP SYNDROME “Mos severe end of pre-eclamptic condition” • H – Haemolysis. • EL -  Liver enzyme. • LP -  Platelet count. “Additional: Haemopoietic system” “Liver involvement”

  9. PATHOLOGICAL FEATURES • Hypertension. • Renal functions. • Hypovolaemia. • Hypoproteinaemia. • Coagulation/fibrinolytic imbalance. • Cerebral irritability. • Placental perfusion.

  10. NORMAL PREGNANCY Vasoconstriction Platelet aggregations Uterine activity Utero-placental blood flow  Thromboxane Vasoconstriction Platelet aggregations Uterine activity Utero-placental blood flow  Prostacyclin

  11. PRE-ECLAMPSIA Vasoconstriction Platelet aggregations Uterine activity Utero-placental blood flow  Prostacyclin Vasoconstriction Platelet aggregations Uterine activity Utero-placental blood flow  Thromboxane

  12. FLUID MANAGEMENT“Important” • Relatively Low PV Low PAWP CO • Endothelial damage. • Low COP • Excessive fluid therapy fetal distress oligurea risk pulmonary oedema

  13. Definitive Delivery of baby Delivery of plaenta MANAGEMENT Symptometic • Control • Blood pressure. • Convulsions. • Fluid balance

  14. MANAGEMENT SYMPTOMATIC HIGH BLOOD PRESSURE • Dangers: Cerebral haemorrhage. Pul oedema • Objective: DBP 90-100mmHg <90 uteroplacentl perfusion

  15. BLOOD PRESSURE • CAUTION. • 4.5% HES 500ml preload. Before IV anti-hypertensive. • EXCEPTION. • Patient post delivery. • Who has 4.5% HES already. • DBP >120.

  16. BLOOD PRESSURE • HYDRALLAZINE • 5mg/5min in 20 min. If BP 90-100 • 40mg/N-saline, 1-5mg/h. • IF AT 20min DBP >100 • 5mg/min in 20 min. If BP 100 • 40mg/N-saline, 1-5mg/h. • IF AT 20min DBP >100 • LABETALOL 10-20mg IV/10min • If DBP 90-100 or • Total 220mg given

  17. BLOOD PRESSURE • Labetalol. • 10-20mg boluses/15min. • If DBP 90-100. • Infusion 5mg/ml (0-160mg/hr). • Ca+ channel blockers. • Nitrates. • Adrenergic neuron blockers.

  18. ECLAMPSIA ROOM • Indications. 1. Eclampsia. 2. Hypertension > 170/110 + Proteinurea > 2+ 3. Hypertension > 140/90 Proteinurea 2+ + One of the symptom/signs

  19. Headaches. Visual disturbances. Hyper-reflexia. Clonus (>3beats). Nausea & vomiting. Epigastric pain. Raised liver enzymes. Thrombocytopenia<100x10/L. SYMPTOM/SIGNS

  20. “MONITORING” Eclampsia Room • ECG. • NIBP. • SPO2. • Fluid balance. • Urine output. • CTG. • CVP.

  21. INTRACELLULAR INTERSTITIAL VASCULAR CAPILLARY EG CELL OSMOLALITY Na+ COP

  22. FLUID BALANCE • Restrict fluids. • (2000ml/24hrs) • Urine output <25ml/hr. • Pass CVP catheter. • CVP • Group A: CVP <4mmHg- underfilled. • Group B: CVP 4-8mmHg- optimialy filled. • Group C: CVP >8mmHg- over filled.

  23. CVP • GROUP - A. • Fluid challenge. • HES 4.5% 100ml. • Bring CVP 4-8. • GROUP - B. • Fluid challenge careful. • CVP 4-8. • Urine O/P <25ml give dopamine.. • GROUP - C. • No pul oedema. • Dopamine 1-3g/kg/min. • Pulmonary oedema present. • Frusemide 20mg. • Refer to ICU.

  24. SEIZURE PROPHYLAXIS “Severe pre-eclampsia” “Controversial” • Magnesium sulphate. • Loading dose 4G. • Infusion 2G/hr. • Optimum level 2-4mmol/L.

  25. Mgnesium (mmol/L) 0.7-1 2-4 >5 >7.5 >10 Effect Normal Therapeutic range. Loss of reflexes. Respiratory depression Cardiac arrest MAGNESIUM SULPHATEBlood Levels

  26. MAGNESIUM SULPHATE • Magnesium level >4 = dose (.5-1G/h) • Magnesium level <1.7=give 2G bolus. dose 2.5G/h. • Magnesium level 1.7-2 continue 2G/h.

  27. MONITORING DURING MAGNESIUM INFUSION • Patellar reflex. • ECG. • SPO2. • Mgnesium level.

  28. MANAGEMENT MAGNESIUM TOXICITY • Loss of patellar reflex. • Stop infusion. • Measure level. • Withold till reflex returns. • Once reflex return – 1G/h. • SPO2 <90%. • Give O2. • Stop maintenance dose. • Measure level. • Inform anaesthetist. • Cardio-respiratory arrest. • Stop infusion. • CPR. • Calcium gluconate. • Intubation/ventilation.

  29. MAGNESIUM THERAPY Considerations • Tocolytic effect. • Interaction – muscle relaxants. • Interaction – calcium antagonists.

  30. “INDICATIONS”ICU – ADMISSION • Severe coagulopathy or DIC. • Recurrent seizures. • Hypertension – poor control. • Persistant oligurea. • Pulmonary oedema + oligurea. • Compromised myocardial function.

  31. Definitive Delivery of baby Delivery of plaenta MANAGEMENT

  32. MANAGEMENTSevere Cases • Arrest & prevention of convulsion. • Barbituates. • Benzodiazepines. • Megnesium SO4. • Paralyse & IPPV. • Blood pressure. • Hypertension – vasodilatation. • Hypotension – inotropics.

  33. MANAGEMENTSevere Cases • Restoration of blood volume. • Low proteins. • Colloids. • Colloid substitutes. • Progressive dehydration. • Replace out put. • Keep BV normal.

  34. ECLAMPSIA“Labour Room” • S.B.P. > 160 Torr. • DBP > 110 Torr. • Protein urea >5G/24h. • Oligurea 500ml or less. • Epigastric pain. • Cyanosis. • Pulmonary oedema. • Convulsions.

  35. IN ICU • B. P. < 80 Torr. • Urine output – nil. • Convulsions. • Pulmonary oedema. • Cyanosis.

  36. CVP Monitoring. Urinary catheter. Nasogastric catheter. Heavy sed with: Valium. Pheno. IPPV. Aemocel 500ml daily Blood 500ml/day. Digitalise. Inotropes if needed. Balance. Negative 7-10day=10-14L Ventilator off 3-4 day. ROUTINE

  37. IDEAL MANAGEMENT • Pass CVP catheter. • Pass urinary catheter. • Pass nasogastric tube. • Replace obvious loss by crystaloids. • Normalise blood volume by colloids. • Remove excess fluids. • From ext vascular comp. • By forced diuresis. • Keep the body in electrolyte balance.

  38. IDEAL MANAGEMENT • Routine investigations. • Hb. • HCT. • Plasma proteins. • Serum Na+ K+. • Monitoring. • Urine output. • ECG. • BP. • Pulse • CVP.

  39. HELLP SYNDROME • H – Haemolysis. • EL – elevated Liver enzyme activity. • LP -  Platelet count. “most sevre end of pre-eclamptic condition”

  40. CLINICAL FEATURES • Epigastric pain. • Upper abdominal tenderness. • Proteinurea. • Hypertension. • Jaundice. • Nausea & vomiting.  • Haematuria. • Oligurea. • A T necrosis. • Cortical necrosis. • Pan-hypopituitarism. • Actue liver rupture • RDS.

  41. MANAGEMENT • Early diagnosis. • Stbilization. • Prompt delivery if. • Pre-eclampsia worsens. • Worsening of hepatic renal functions. • Severe thrombocytopenia. • Gestational age at or beyond 32-34wks. • Evidence of foetal distess. • Evidence of foetal maturity.

  42. MANAGEMENT • Pre-op investigations. • Platelet count. • PCV. • Hb. • PTT. • Fibrinogen concentration. • FDP. • LFTs. • Creatinine. • Urea. • Uric acid. • X-ray chest.

  43. Platelet infusion if. • <50000mm-3 cs. • <20000mm-3 vag.D. • Blood transfusion if. • B <10.0G/dl. • Hb. • PPF. • FFP. • CVP. • Urine output. • Maternal blood glucose control. • IPPV.

More Related